Differential Diagnosis and Clinical Treatment Strategies of Thyroid Nodules.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02953288

Enrollment

3000

Registered

2016-11-02

Start date

2016-10-31

Completion date

2018-12-31

Last updated

2016-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Cancer

Brief summary

To investigate the genetic mutations of patients with thyroid carcinoma and find molecular targets for therapy.

Detailed description

In previous studies, we have found highly prevalent TERT promoter mutations in aggressive thyroid cancers. So we plan to perform further research to investigate the genetic mutations of patients with thyroid carcinoma and find molecular targets for therapy.

Interventions

None listed

Study design

Observational model

CASE_CROSSOVER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Patient with thyroid nodule

Exclusion criteria

* Coagulant function abnormality * pregnant

Design outcomes

Primary

Measure	Time frame
Gene sequencing	2 weeks

Countries

China

Outcome results